Pages that link to "Q37983692"
Jump to navigation
Jump to search
The following pages link to Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies (Q37983692):
Displaying 50 items.
- Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents (Q26740567) (← links)
- Assessing Tumor Response to Treatment in Patients with Lung Cancer Using Dynamic Contrast-Enhanced CT (Q26741729) (← links)
- Pharmacodynamic Biomarker Development for PI3K Pathway Therapeutics (Q26766292) (← links)
- Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trials (Q26822432) (← links)
- Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging (Q27334823) (← links)
- Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases (Q28247245) (← links)
- Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response (Q28384680) (← links)
- High-resolution whole-brain DCE-MRI using constrained reconstruction: Prospective clinical evaluation in brain tumor patients (Q28600963) (← links)
- Imaging biomarker roadmap for cancer studies (Q30242020) (← links)
- Bolus arrival time and its effect on tissue characterization with dynamic contrast-enhanced magnetic resonance imaging. (Q30353922) (← links)
- Biomarkers in preclinical cancer imaging. (Q30416864) (← links)
- Vessel caliber--a potential MRI biomarker of tumour response in clinical trials. (Q30651792) (← links)
- Mixed-effects modeling of clinical DCE-MRI data: application to colorectal liver metastases treated with bevacizumab. (Q30806067) (← links)
- Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling. (Q30810422) (← links)
- Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge (Q30810438) (← links)
- Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer? (Q30814598) (← links)
- Blood-brain barrier imaging in human neuropathologies (Q30873200) (← links)
- MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity. (Q30881669) (← links)
- GPU-accelerated compartmental modeling analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab. (Q30912225) (← links)
- State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications (Q30928967) (← links)
- Improved T1, contrast concentration, and pharmacokinetic parameter quantification in the presence of fat with two-point Dixon for dynamic contrast-enhanced magnetic resonance imaging (Q30954074) (← links)
- Assessing Treatment Response Through Generalized Pharmacokinetic Modeling of DCE-MRI Data (Q30990964) (← links)
- Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison study (Q31106171) (← links)
- Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model (Q31119452) (← links)
- Reconstruction of Undersampled Big Dynamic MRI Data Using Non-Convex Low-Rank and Sparsity Constraints. (Q31172614) (← links)
- Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates (Q33410972) (← links)
- Nanoparticle-Based Magnetic Resonance Imaging on Tumor-Associated Macrophages and Inflammation (Q33710955) (← links)
- Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy (Q34050862) (← links)
- Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data. (Q34269947) (← links)
- Regorafenib for cancer (Q34274239) (← links)
- Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models (Q34430739) (← links)
- Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study (Q34465123) (← links)
- Unsupervised deconvolution of dynamic imaging reveals intratumor vascular heterogeneity and repopulation dynamics (Q34473011) (← links)
- NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures (Q34478588) (← links)
- Antiangiogenic therapy for glioblastoma: current status and future prospects (Q34523319) (← links)
- DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas (Q34582022) (← links)
- Gaussian mixture model-based classification of dynamic contrast enhanced MRI data for identifying diverse tumor microenvironments: preliminary results (Q34601310) (← links)
- The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck. (Q34635573) (← links)
- Early detection of Lewis lung carcinoma tumor control by irradiation using diffusion-weighted and dynamic contrast-enhanced MRI. (Q34712745) (← links)
- Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer (Q34754728) (← links)
- Dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors (Q35077659) (← links)
- Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis. (Q35110740) (← links)
- Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review (Q35402503) (← links)
- Dynamic contrast-enhanced MR microscopy identifies regions of therapeutic response in a preclinical model of colorectal adenocarcinoma (Q35537599) (← links)
- Dependence of DCE-MRI biomarker values on analysis algorithm (Q35711964) (← links)
- Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging (Q35843084) (← links)
- Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma (Q35863135) (← links)
- Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. (Q35895174) (← links)
- Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI. (Q38637118) (← links)
- A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer (Q36076814) (← links)